RB

Rakesh Balakrishnannair

Active Director Managing Director DIN 11336416
DIN 11336416 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Balakrishnannair

Data last updated:

Rakesh Balakrishnannair is a Managing Director at Habex Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11336416
Primary Designation Managing Director
Industry Pharma
First Appointment 10 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Habex Lifesciences Private Limited U46497KL2025PTC097771
Managing Director10 Oct 20252025Active

Board colleagues of Rakesh Balakrishnannair

Directorship timeline

Open interactive timeline →
Habex Lifesciences Private Limited
Premium access

Shareholding and investment profile for Rakesh Balakrishnannair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Balakrishnannair

Rakesh Balakrishnannair currently holds 1 directorship: Habex Lifesciences Private Limited (Managing Director, since 10 Oct 2025).

Rakesh Balakrishnannair was first appointed on 10 Oct 2025 as Managing Director at Habex Lifesciences Private Limited.

The current boards of Rakesh Balakrishnannair's companies include Mohammad Siya Muhammadkunju (Habex Lifesciences Private Limited), Sreejith (Habex Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available